Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 14, Issue 4, pp. 1035-1047
PubMed
Published By
Print ISSN
Online ISSN
History
- Received September 17, 2014
- Revision received December 18, 2014
- Accepted January 26, 2015
- Published first February 2, 2015.
Article Versions
- Previous version (February 2, 2015 - 11:43).
- Previous version (March 27, 2015 - 07:01).
- You are viewing the most recent version of this article.
Copyright & Usage
©2015 American Association for Cancer Research.
Author Information
- Galina Gritsina1,
- Fang Xiao1,
- Shane W. O'Brien1,
- Rashid Gabbasov1,2,
- Marisa A. Maglaty1,
- Ren-Huan Xu3,
- Roshan J. Thapa3,
- Yan Zhou4,
- Emmanuelle Nicolas5,
- Samuel Litwin4,
- Siddharth Balachandran3,
- Luis J. Sigal3,
- Dennis Huszar6, and
- Denise C. Connolly1,*
- 1Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
- 2Kazan (Volga Region) Federal University, Kazan, Russia.
- 3Immune Cell Development and Host Defense Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
- 4Biostatistics Facility, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
- 5Genomics Facility, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
- 6AstraZeneca Oncology iMed, Waltham, Massachusetts.
- ↵*Corresponding Author:
Denise C. Connolly, Molecular Therapeutics Program, Fox Chase Cancer Center, 333 Cottman Avenue, W310, Philadelphia, PA 19111. Phone: 215-728-1004; Fax: 215-728-2741; E-mail: Denise.Connolly{at}fccc.edu
April 2015
Volume 14, Issue 4
Volume 14, Issue 4
Targeted Blockade of JAK/STAT3 Signaling Inhibits Ovarian Carcinoma Growth
Jump to section
Advertisement